Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	View
CXSL2101501	重组人胰高糖素样肽1修饰抗人葡萄糖依赖性促胰岛素释放肽受体的人源化单克隆抗体注射液	GMA-106	Injection	Biological Products(1)	New Drug Application	2021-12-22	Hongyun Huaning (Hangzhou) Biomedical Co Ltd	view
CXSB2500076	重组人胰高糖素样肽1修饰抗人葡萄糖依赖性促胰岛素释放肽受体的人源化单克隆抗体注射液	GMA-106	Injection	Biological Products(1)	Supplementary Application	2025-05-22	Zhengda Pharmaceutical (Guangzhou) Co Ltd	view
CXSB2400064	重组人胰高糖素样肽1修饰抗人葡萄糖依赖性促胰岛素释放肽受体的人源化单克隆抗体注射液	GMA-106	Injection	Biological Products(1)	Supplementary Application	2024-06-21	Nanjing Shunxin Pharmaceuticals Co LTDof Chiatai Tianqing Pharmaceutical Group;Zhengda Pharmaceutical (Guangzhou) Co Ltd	view
CXSB2300102	重组人胰高糖素样肽1修饰抗人葡萄糖依赖性促胰岛素释放肽受体的人源化单克隆抗体注射液	GMA-106	Injection	Biological Products(1)	Supplementary Application	2023-09-25	Zhengda Pharmaceutical (Guangzhou) Co Ltd	view